Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor α chain 1: Redundancy of requirement of tyrosine residue for STAT3 activation

International Immunology

Volumn 12, Issue 11, 2000, Pages 1499-1509

  Umeshita Suyama, Ritsuko ^a,b   Sugimoto, Rie ^a   Akaiwa, Mina ^a   Arima, Kazuhiko ^a   Yu, Bin ^a   Wada, Morimasa ^a   Kuwano, Michihiko ^a   Nakajima, Koichi ^c   Hamasaki, Naotaka ^a   Izuhara, Kenji ^a,d  

^a KYUSHU UNIVERSITY   (Japan)

^b UNITIKA LTD   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SAGA UNIVERSITY   (Japan)

Author keywords

B cell; Jak1; Jak3; STAT6

Indexed keywords

INSULIN RECEPTOR KINASE; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; JANUS KINASE; RECEPTOR SUBUNIT; STAT3 PROTEIN; STAT6 PROTEIN; TYROSINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CARBOXY TERMINAL SEQUENCE; CELL STRAIN; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

EID: 0033729988     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.11.1499     Document Type: Article

References (59)

1. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells
2. Activated mast cells produce interleukin 13
3. Effects of T(h)2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells
4. Regulation of 15-lipoxygenase expression and mucus secretion by IL-4 in human bronchial epithelial cells
5. IL-13 is a key regulatory cytokine for T(h)2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs
6. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses
7. Interleukin-13: Central mediator of allergic asthma
8. Requirement for IL-13 independently of IL-4 in experimental asthma
9. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
10. Genetic variants of IL-13 signalling and human asthma and atopy
11. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children
12. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor
13. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain
14. cDNA cloning and characterization of the human interleukin 13 receptor α chain
15. The murine IL-13 receptor α2:Molecular cloning, characterization, and comparison with murine IL-13 receptor α1
16. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors
17. An interleukin (IL)-13 receptor lacking the cytoplasmic domain fails to transduce IL-13-induced signals and inhibits response to IL-4
18. Interleukin-13 receptor α' but not α chain: A functional component of interleukin-4 receptors
19. The signal transduction : A the interleukin-4 receptor and its correlation with atopy
20. The IL-4 receptor: Signaling mechanisms and biologic functions
21. Interleukin-13 signal transduction in lymphohemopoietic cells: Similarities and differences in signal transduction with interleukin-4 and insulin
22. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15
23. IL4 and IL13 receptors share the γ(c) chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells
24. Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients
25. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: Similarities between IL-4 and IL-13 signaling
26. Activation of phosphatidylinositol 3-kinase by interleukin-13. An inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29
27. Characterization of the cytoplasmic domain of interleukin-13 receptor-α
28. Structural characterization of the human interleukin-13 receptor α1 gene promoter
29. Rapid and efficient site-specific mutagenesis without phenotypic selection
30. Antagonistic effects of an alternative splice variant of human IL-4, IL-4δ2, on IL-4 activities in human monocytes and B cells
31. Dominant effect of Ile50Val variant of the human interleukin-4 receptor α chain in IgE synthesis
32. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway
33. Cytokine receptor signaling
34. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2
35. Involvement of the Jak-3 Janus kinase in signalling by interleukin 2 and 4 in lymphoid and myeloid cells
36. Prevention of T cell anergy by signalling through the γ(c) chain of the IL-2 receptor
37. JAK1 kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes
38. Interaction of IL-2Rβ and γ(c) chains with Jak1 and Jak3: Implications for XSCID and XCID
39. The IL-4-induced tyrosine phosphorylation of the insulin receptor substrate is dependent on JAK1 expression in human fibrosarcoma cells
40. Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules
41. Signaling through the hematopoietic cytokine receptors
42. Regulation of interleukin-13 receptor constituents on mature human B lymphocytes
43. Protein-tyrosine kinase-dependent activation of STAT transcription factors in interleukin-2- or interleukin-4-stimulated T lymphocytes
44. Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases
45. Receptors for interleukin-3 (IL-3) and growth hormone mediate an IL-6-type transcriptional induction in the presence of JAK2 or STAT3
46. STAT6, NF-κB and C/EBP in CD23 expression and IgE production
47. Identification of a novel Stat3 recruitment and activation motif within the granulocyte colony-stimulating factor receptor
48. Association of Stat3-dependent transcriptional activation of p19INK4D with IL-6-induced growth arrest
49. Autoregulation of the Stat3 gene through cooperation with a cAMP-responsive element-binding protein
50. STAT3 is required for the gp130-mediated full activation of the c-myc gene
51. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation
52. Two signals are necessary for cell proliferation induced by a cytokine receptor gp 130: Involvement of STAT3 in anti-apoptosis
53. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
54. Involvement of Stat3 in interleukin-6-induced IgM production in a human B-cell line
55. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells
56. Receptor for interleukin 13: Interaction with interleukin 4 by a mechanism that does not involve the common γ chain shared by receptors for interleukins 2, 4, 7, 9, and 15
57. Association of the interleukin-4 receptor α chain with p47(phox), an activator of the phagocyte NADPH oxidase in B cells
58. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways
59. Interleukin-4 signaling in B lymphocytes from patients with X-linked severe combined immunodeficiency